Trade VERU stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Veru Inc. (VERU) is trading at US$2.30, down 5.74% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$45.01M. Over the past 52 weeks, VERU has traded between US$2.05 and US$7.33. On Syfe you can trade VERU with $0 commission and add it to your watchlist.
| Previous close | US$2.44 |
|---|---|
| Market cap | US$45.01M |
| 52-week range | US$2.05 – US$7.33 |
| Volume | 305.31K |
| Exchange | US |
Veru Inc.
Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.
Year: 1990
Sector Update: Healthcare Stocks Advance Late Afternoon
Jul 27, 7:56 PM · MT Newswires
Sector Update: Healthcare
Jul 27, 7:31 PM · MT Newswires
Veru Completes Enrollment in Phase 2 Obesity Study
Jul 27, 1:06 PM · MT Newswires
Veru Enters Supply Agreement With Novo Nordisk for Obesity Study; Shares Surge
Jun 4, 5:09 PM · MT Newswires
--Oppenheimer Adjusts Price Target on Veru to $24 From $25, Maintains Outperform Rating
May 15, 1:09 PM · MT Newswires
Veru Inc. (VERU) stock is trading at US$2.30, -5.74% from the previous close of US$2.44.
The market cap for Veru Inc. (VERU) stock is approximately US$45.01M.
The 52-week high for Veru Inc. (VERU) stock is US$7.33.
The 52-week low for Veru Inc. (VERU) stock is US$2.05.
Veru Inc. (VERU) does not currently pay a dividend.
Stay on top of VERU
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
